Header and Body 4

Advantages

  • Paper-based lateral flow assays for Zika and Ebola developed from existing cross-reactive antibodies
  • Capable of distinguishing between emergent disease and related family member (ex. Zika and Dengue or Ebola and Marburg virus) through the use of colorimetric nanoparticles
  • Generalizable strategy to rapidly generate diagnostics for emerging infectious diseases